Table: Hisamitsu -Q1 group results

Hisamitsu Pharmaceutical Co

13/07/2023 07:00

Jul 13 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2023        May 31, 2022     Feb 29, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               32.10               26.39           132.30    
                   (+21.6 pct)         (-4.9 pct)       (+3.1 pct)  
  Operating            4.36              519 mln           11.80    
                  (+739.1 pct)         (-75.5 pct)      (+1.7 pct)  
  Recurring            5.71                2.30            14.60    
                  (+148.6 pct)         (-19.5 pct)      (-9.0 pct)  
  Net                  4.05                1.63            10.60    
                  (+148.2 pct)         (-30.9 pct)      (-9.7 pct)  
  EPS               52.09 yen           20.46 yen       136.34 yen  
  EPS Diluted       52.05 yen           20.45 yen                   
  Ann Div                               84.50 yen        85.00 yen  
  -Q2 div                               42.25 yen        42.50 yen  
  -Q4 div                               42.25 yen        42.50 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T